Medicus Pharma (MDCX) announces that its phase 2 clinical study, SKNJCT-003, which is currently underway in nine clinical sites in United ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Apellis Pharmaceuticals (APLS – Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback